Sarepta Therapeutics(SRPT)
Search documents
Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)
2021-01-11 17:34
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) 39th Annual JPMorgan Virtual Healthcare Conference January 11, 2021 10:00 AM ET Company Participants Doug Ingram - CEO Gilmore O'Neill - Head of R&D Louise Rodino-Klapac - Chief Scientific Officer Dallan Murray - Chief Commercial Officer Ian Estepan - CFO Conference Call Participants Anupam Rama - JPMorgan Tessa Romero - JPMorgan Anupam Rama Welcome everyone to the 39th Annual J.P. Morgan Healthcare Conference. My name is Anupam Rama. I am one of the senior biotech a ...
Sarepta Therapeutics (SRPT) Special Call - Slideshow
2020-12-11 21:15
| --- | --- | --- | --- | |-------------------------------|-----------------------------------------------------------------------------------------------------|----------------------------------------------------------|-------| | | | | | | | | | | | | Clinical Update: MOMENTUM MultipleAscending Dose Study of SRP-5051 for Duchenne Muscular Dystrophy | | | | | | | | | DOUG INGRAM | GILMORE O'NEILL , MB, MMSC | | | | President and CEO | Executive Vice President, R&D and Chief Medical Officer | | | | December ...
Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram on MOMENTUM Multiple-Ascending Dose Study of SRP-5051 for Duchenne Muscular Dystrophy Conference (Transcript)
2020-12-07 21:15
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) MOMENTUM Multiple-Ascending Dose Study of SRP-5051 for Duchenne Muscular Dystrophy Conference Call December 7, 2020 8:30 AM ET Company Participants Doug Ingram - President and Chief Executive Officer Gilmore O’Neill - Executive Vice President, R&D Conference Call Participants Salveen Richter - Goldman Sachs Tazeen Ahmad - Bank of America Gena Wang - Barclays Alethia Young - Cantor Brian Skorney - Baird Anupam Rama - JPMorgan Matthew Harrison - Morgan Stanley Tyler Va ...
Sarepta Therapeutics, Inc. (SRPT) Presents at Evercore ISI HealthCONx Conference - (Transcript)
2020-12-02 23:01
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Evercore ISI HealthCONx Conference December 2, 2020 3:30 PM ET Company Participants Douglas Ingram - President, CEO & Director Conference Call Participants Maneka Mirchandaney - Evercore ISI Maneka Mirchandaney Great. Good afternoon, everyone. I'm Maneka Mirchandaney from the Evercore ISI biotech team. I am really pleased to be here with Sarepta. We've got Doug Ingram, who's its President and CEO; and Ian Esteban, who's SVP, Chief of Staff and Corporate Affairs. Than ...
Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram Presents at Credit Suisse 29th Annual Virtual Healthcare Conference (Transcript)
2020-11-10 05:09
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Credit Suisse 29th Annual Virtual Healthcare Conference November 9, 2020 3:30 PM ET Company Participants Doug Ingram - Chief Executive Officer Conference Call Participants Martin Auster - Credit Suisse Martin Auster This is Martin Auster. I am the lead Smid cap Biotech Analyst at Credit Suisse. Thanks for joining us at the 29th Annual Credit Suisse Healthcare Conference. I’ve got Doug Ingram, CEO, along with some members of the Sarepta Therapeutics team. Very happy ...
Sarepta Therapeutics(SRPT) - 2020 Q3 - Earnings Call Transcript
2020-11-06 03:42
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q3 2020 Results Conference Call November 5, 2020 4:30 PM ET Company Participants Mary Jenkins - Senior Manager, IR Doug Ingram - President and CEO Ian Estepan - SVP, Chief of Staff and Corporate Affairs Dr. Gilmore OÂ'Neill - EVP, R&D and Chief Medical Officer Conference Call Participants Jack Allen - Baird Tazeen Ahmad - Bank of America Emma Nealon - Cantor Fitzgerald Anupam Rama - J.P. Morgan Gena Wang - Barclays Joseph Schwartz - SVB Leerink Colin Bristow - UBS Br ...